Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001111928-26-000094
- form_type
- 8-K
- ticker
- IPGP
- cik
- 0001111928
- company_name
- IPG PHOTONICS CORP
- filed_at
- 2026-05-05T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:31.969527+00:00
- generated_at
- 2026-05-14T23:13:12.858893+00:00
- sec_items
- ["2.02", "8.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.65
- calibrated_materiality_score
- 0.65
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001111928-26-000094
- json_url
- https://secwatch.observer/filing/0001111928-26-000094.json
- markdown_url
- https://secwatch.observer/filing/0001111928-26-000094.md
- text_url
- https://secwatch.observer/filing/0001111928-26-000094.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/ipgp-20260505.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
ARTV
Artiva reports 71% ACR50 in refractory RA at 6 months, FDA alignment for Phase 3 trial; Q1 net loss $23.5M
Artiva Biotherapeutics, Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 2.02, 7.01, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
same event type: other_material
This filing
Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %
Comparable filing
Artiva Biotherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2026.
Filing page
SEC filing
YEXT
Yext Q1 FY27: Adj EBITDA margin 25%, ARR $440.8M; boosts buyback by $100M
Yext, Inc.
June 2, 2026, 4:05 PM ET
earnings
Items 2.02, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
similar materiality
This filing
Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %
Comparable filing
Exchange Act, except as expressly set forth by specific reference in such a filing.
--- EX-99.1 (EX-99.1) ---
Yext Announces First Quarter Fiscal 2027 Results – Revenue of $107.9 million – Net Income Per Share, basic, of $0.02 or non-GAAP Net Income Per Share of $0.15 – Adjusted EBITDA of $26.9 million, resulting in an Adjusted EBITDA margin of 25% – ARR of
Filing page
SEC filing
SNDA
Sonida Senior Living reports Q1 net loss of $41.2M; revenue up 37% on CHP acquisition
SONIDA SENIOR LIVING, INC.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
similar materiality
This filing
Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %
Comparable filing
Sonida Senior Living Announces First Quarter 2026 Results DALLAS, Texas – May 11, 2026 – Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the first quarter ended March 31, 2026.
Filing page
SEC filing
LXEO
Lexeo Therapeutics Q1 net loss $20.2M; cash $227.6M; LX2006 pivotal trial protocol submitted to FDA
Lexeo Therapeutics, Inc.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
similar materiality
This filing
Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %
Comparable filing
Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights
Filing page
SEC filing
CRON
Cronos Q1 net revenue up 40% to $45.2M; authorizes $50M share buyback; CanAdelaar close extended to Sep 9
Cronos Group Inc.
May 11, 2026, 7:59 PM ET
earnings
Items 1.01, 2.02, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
similar materiality
This filing
Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %
Comparable filing
reference in such a filing or document.
--- EX-99.1 (EX-99.1) ---
Cronos Group Reports 2026 First Quarter Results Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada 1 Ninth consecutive quarter of record net revenue in Israel, where PEACE
Filing page
SEC filing
CERT
Certara Q1 revenue $106.9M (+1%), net loss $8.8M; divests Regulatory Writing for $85M cash
Certara, Inc.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
similar materiality
This filing
Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %
Comparable filing
First Quarter 2026 Results Total revenue for the first quarter of 2026 was $106.9 million, representing year-over-year growth of 1% on a reported basis. Software revenue for the first quarter of 2026 was $49.7 million, representing year-over-year growth of 7% on a reported basis. Services revenue for the first quarter of 2026 was $57.2 million, representing a year-over-year decrease of 4% on a reported basis . Total Bookings for the first quarter of 2026 were $115.3 million, representing a year-over-year decrease of 2%. Software Bookings for the first quarter of 2026 were $48.7 million, representing a year-over-year increase of 20%. The increase in software bookings was attributable to strong customer demand across our platform. Services Bookings for the first quarter of 2026 were $66.6 million, representing a year-over-year decrease of 14%. The decrease in services bookings was primarily driven by the timing of contract recognition and execution. Total cost of revenues for the first q
Filing page
SEC filing
RPC
Ridgepost Capital reports record AUM of $31B in Q1 2026, up 18% YoY
Ridgepost Capital, Inc.
May 8, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
similar materiality
This filing
Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %
Comparable filing
Ridgepost Capital, Inc (NYSE: RPC), a leading private markets solutions provider, today announced financial results for the first quarter ended March 31, 2026.
Filing page
SEC filing
ASIX
AdvanSix Q1 net loss $15.5M; sales up 7% to $404M; declares $0.16 dividend; appoints new CFO
AdvanSix Inc.
May 8, 2026, 7:59 PM ET
earnings
Items 2.02, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
similar materiality
This filing
Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %
Comparable filing
the second quarter." Summary first quarter 2026 financial results for the Company are included below: 1 ( $ in Thousands, Except Earnings Per Share) 1Q 2026 1Q 2025 (1) Sales $404,183 $377,791 Net Income (loss) (15,546) 23,344 Diluted Earnings Per Share (0.58) 0.86 Adjusted Diluted Earnings Per Share (2) (0.50) 0.93 Adjusted EBITDA (2) 4,756 51,626 Adjusted
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.